Our sector specialties include: Consumer; Healthcare; Media; Power & Energy Transition; and Technology. Guggenheim Equity Research analysts average 18 years of Wall Street and industry experience, bringing our clients rich perspectives and deep domain expertise.
Rigorous primary research is central to our approach. Innovation and disruption are constants in the sectors we cover and on-the-ground work keeps our team at the leading edge of trend changes for the benefit of our clients. Our signature research products uncover these findings and include:
The Consumer team covers automotive, e-commerce, hardline and softline retail, and restaurants.
The Healthcare team covers biotechnology, biopharmaceuticals, diagnostics and life sciences tools, and healthcare services.
The Power & Energy Transition team covers energy & industrial technology, power, and utilities.
For access to our research offerings and products, please contact your Guggenheim Securities Sales representative or email GSInfo@guggenheimpartners.com.
Already Registered? View the content library on the research portal (login required).
Diagnostics and Life Sciences Tools
AI-Driven Drug Discovery, Development & the Outlook for Life Sciences Tools
I&I Spotlight Series – Treg-based Therapies
Senior Managing Directors Whitney Wolfe and Yatin Suneja partake in a Q&A session regarding the future of the Treg-Therapies.
Highlights From the Second Guggenheim Targeted Protein Day
Senior Managing Director Michael Schmidt discusses the key topics from the event.
| Date | Sector | Location | Conference Name |
|---|---|---|---|
Vamil Divan Joins CNBC to Preview Therapeutics Earnings Results
Global Biopharmaceuticals and Biotechnology Equity Research Analyst Vamil Divan, MD, MBA recently joined CNBC's "Morning Call" with Dominic Chu to preview earnings results and analyze the therapeutics pipeline for one of the largest global pharmaceutical companies.
Michael Morris Speaks With LA Times About Lawsuit to Block a Massive Media Consolidation Transaction
Media & Internet Equity Research Analyst Michael Morris spoke with Meg James of the Los Angeles Times about the recent filing of a lawsuit by a coalition of 12 state attorneys general to block one of the largest media consolidation transactions of all-time. Morris provided analysis of the risks that both sides face in the case.
John DiFucci Joins Yahoo Finance to Discuss Thematic Report on AI
Software Equity Research Analyst John DiFucci recently joined Yahoo Finance’s Josh Lipton to discuss his recent thematic report about the potential impacts of artificial intelligence on the software industry. DiFucci also shared his outlook for AI monetization within the software sector and why he expects pricing for AI to eventually settle in a way that makes sense for both the enterprise and AI vendor.
